Table 1 Clinical and biochemical characteristics of participants
Characteristic | N = 148 |
|---|---|
cardiovascular autonomic neuropathy(%) | 78(52.7) |
Age(years) | 59.8 ± 7.8 |
Male,n(%) | 80(54.0) |
Current smoker, n (%) | 43(29.0) |
Alcohol consumption, n (%) | 37(25.0) |
Hypertension, n (%) | 81(54.7) |
Use of β-Blockers | 34(22.9) |
Use of ACEI/ARB | 67(45.3) |
Use of CCB | 48(32.4) |
Other antihypertensives | 14(9.5) |
Express as median(years) | 6.0(2.0-11.0) |
BMI(kg/m2) | 24.4 ± 3.4 |
Waist-to-hip ratio | 0.94(0.90-0.99) |
systolic blood pressure(mmHg) | 134.2 ± 18.1 |
diastolic blood pressure(mmHg) | 78.3 ± 10.6 |
HbA1c(%) | 8.0 ± 1.9 |
fasting glucose(mmol/l) | 7.1(5.8-9.2) |
Creatinine (μmol/L) | 62.0(53.0-78.0) |
eGFR( ml/min/1.73 m2) | 107.0 ± 32.8 |
total cholesterol(mmol/l) | 4.89 ± 1.52 |
Triglyceride(mmol/l) | 1.61(1.05-2.34) |
LDL cholesterol(mmol/l) | 2.84(2.29-3.60) |
HDL cholesterol(mmol/l) | 1.09(0.93-1.33) |
ACR(mg/g) | 12.02(7.18-19.54) |
baPWV(cm/sec) | 1665.5(1482.0-1940.0) |
Diabetic retinopathy, n (%) | 25(16.9) |
Diabetic peripheral neuropathy, n (%) | 46(31.1) |
NSS score | 5.0(2.0-6.0) |
NDS score | 4.0(2.0-5.0) |
Diabetic nephropathy, n (%) | 33(22.2) |